Civic Intelligence

Global Oncology Inc

990 • Fiscal year 2014 • EIN 46-4061142

Jan 01, 2014 to Dec 31, 2014

Oakland, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Liabilities / Revenue

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Net Margin

98th percentile

87%

Higher net margin than 98% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2014

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2014

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2014

Assets

$170,899

No earlier filing loaded for comparison.

Net Assets

$170,899

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$196,795

No earlier filing loaded for comparison.

Expenses

$25,896

No earlier filing loaded for comparison.

Net Income

$170,899

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2014: $170,899Liabilities 2014: $0Net Assets 2014: $170,8992014Assets 2015: $199,927Liabilities 2015: $810Net Assets 2015: $199,1172015Assets 2016: $355,863Liabilities 2016: $8,361Net Assets 2016: $347,5022016Assets 2017: $232,378Liabilities 2017: $5,790Net Assets 2017: $226,5882017Assets 2018: $182,532Liabilities 2018: $4,465Net Assets 2018: $178,0672018Assets 2019: $171,246Liabilities 2019: $2,434Net Assets 2019: $168,8122019Assets 2020: $253,395Liabilities 2020: $11,011Net Assets 2020: $242,3842020Assets 2021: $299,403Liabilities 2021: $7,129Net Assets 2021: $292,2742021Assets 2022: $344,266Liabilities 2022: $2,985Net Assets 2022: $341,2812022Assets 2023: $465,160Liabilities 2023: $8,093Net Assets 2023: $457,0672023Assets 2024: $393,072Liabilities 2024: $867Net Assets 2024: $392,2052024

Highlighted filing

2014

Assets$170,899
Liabilities$0
Net Assets$170,899

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2014: $196,795Expenses 2014: $25,896Net Income 2014: $170,8992014Revenue 2015: $135,278Expenses 2015: $107,060Net Income 2015: $28,2182015Revenue 2016: $406,334Expenses 2016: $257,953Net Income 2016: $148,3812016Revenue 2017: $150,700Expenses 2017: $271,614Net Income 2017: -$120,9142017Revenue 2018: $180,768Expenses 2018: $229,289Net Income 2018: -$48,5212018Revenue 2019: $179,738Expenses 2019: $188,993Net Income 2019: -$9,2552019Revenue 2020: $195,551Expenses 2020: $121,979Net Income 2020: $73,5722020Revenue 2021: $188,636Expenses 2021: $138,746Net Income 2021: $49,8902021Revenue 2022: $157,540Expenses 2022: $108,533Net Income 2022: $49,0072022Revenue 2023: $205,554Expenses 2023: $89,768Net Income 2023: $115,7862023Revenue 2024: $102,322Expenses 2024: $167,184Net Income 2024: -$64,8622024

Highlighted filing

2014

Revenue$196,795
Expenses$25,896
Net Income$170,899
Filing Detail Status

This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Mission and Program Overview

Mission

Global oncology's mission is to bring the best in cancer care to underserved patients around the world. The global oncology 2016-2019 strategic framework will guide our strategic goals and specific objectives towards sustainable and scalable actions in the global fight against cancer. Initally we will focus our efforts, resources and collaboration on selected high-need regions where we can partner effectively with local care delivery teams. We will broadly share best practices and tools developed through global oncology's efforts to maximize impact. With additional support and partnerships, we plan to expand the application of our scalable solutions to additional geographic areas.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings